A detailed history of Group One Trading, L.P. transactions in Cor Medix Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 48,366 shares of CRMD stock, worth $348,718. This represents 0.01% of its overall portfolio holdings.

Number of Shares
48,366
Previous 24,329 98.8%
Holding current value
$348,718
Previous $103,000 102.91%
% of portfolio
0.01%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.08 - $6.39 $98,070 - $153,596
24,037 Added 98.8%
48,366 $209,000
Q1 2024

May 10, 2024

SELL
$2.94 - $4.24 $48,956 - $70,604
-16,652 Reduced 40.63%
24,329 $103,000
Q4 2023

Feb 14, 2024

SELL
$3.0 - $4.01 $24,525 - $32,781
-8,175 Reduced 16.63%
40,981 $154,000
Q3 2023

Nov 09, 2023

SELL
$3.6 - $4.46 $19,832 - $24,570
-5,509 Reduced 10.08%
49,156 $181,000
Q2 2023

Aug 09, 2023

BUY
$3.94 - $5.8 $169,423 - $249,405
43,001 Added 368.66%
54,665 $216,000
Q1 2023

May 12, 2023

SELL
$3.22 - $4.61 $16,740 - $23,967
-5,199 Reduced 30.83%
11,664 $48,000
Q4 2022

Feb 09, 2023

SELL
$2.81 - $4.45 $62,663 - $99,235
-22,300 Reduced 56.94%
16,863 $71,000
Q3 2022

Nov 09, 2022

BUY
$2.82 - $7.52 $110,439 - $294,505
39,163 New
39,163 $111,000
Q4 2021

Feb 11, 2022

SELL
$4.47 - $5.56 $13,713 - $17,058
-3,068 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$4.46 - $7.11 $13,683 - $21,813
3,068 New
3,068 $14,000
Q1 2021

May 12, 2021

SELL
$6.84 - $17.58 $87,661 - $225,305
-12,816 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$5.0 - $9.15 $64,080 - $117,266
12,816 New
12,816 $95,000
Q3 2020

Nov 12, 2020

SELL
$3.96 - $6.15 $13,832 - $21,481
-3,493 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$3.08 - $6.56 $10,758 - $22,914
3,493 New
3,493 $22,000
Q1 2020

May 13, 2020

SELL
$2.35 - $7.08 $83,511 - $251,601
-35,537 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$4.96 - $7.75 $73,918 - $115,498
14,903 Added 72.23%
35,537 $259,000
Q3 2019

Nov 12, 2019

BUY
$6.38 - $9.69 $131,644 - $199,943
20,634 New
20,634 $132,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $297M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.